Press "Enter" to skip to content

Children aged 12-15 can be used with favipiravir

The Ministry of Health changed the Kovid-19 Pediatric Patient Management and Treatment Guide.

Favipiravir It was previously used in the treatment of children 15 years and older with Covid-19. Use of favipiravir after the change is made between the ages of 12-15 childIt has also been made to cover.

Accordingly, favipiravir can be used with the consent form in the treatment of children with Covid-19 between the ages of 12-15. Another change was made in the section for children with risk factors.

Underlying immunodeficiency or immunosuppressive drug intake, chronic diseases stated as risk factors in this section, β€œIn childhood; cerebral palsy, neurological development problems, obesity, genetic syndromes (trisomy 21), cardiopulmonary disease and immunocompromised children and adolescents.

Download the NTV application, be informed about the developments

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *